解析抗疟化合物FR-900098的后期生物合成步骤。
Deciphering the late biosynthetic steps of antimalarial compound FR-900098.
作者信息
Johannes Tyler W, DeSieno Matthew A, Griffin Benjamin M, Thomas Paul M, Kelleher Neil L, Metcalf William W, Zhao Huimin
机构信息
Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
出版信息
Chem Biol. 2010 Jan 29;17(1):57-64. doi: 10.1016/j.chembiol.2009.12.009.
Abstract
FR-900098 is a potent chemotherapeutic agent for the treatment of malaria. Here we report the heterologous production of this compound in Escherichia coli by reconstructing the entire biosynthetic pathway using a three-plasmid system. Based on this system, whole-cell feeding assays in combination with in vitro enzymatic activity assays reveal an unusual functional role of nucleotide conjugation and lead to the complete elucidation of the previously unassigned late biosynthetic steps. These studies also suggest a biosynthetic route to a second phosphonate antibiotic, FR-33289. A thorough understanding of the FR-900098 biosynthetic pathway now opens possibilities for metabolic engineering in E. coli to increase production of the antimalarial antibiotic and combinatorial biosynthesis to generate novel derivatives of FR-900098.
摘要
FR-900098是一种用于治疗疟疾的强效化疗药物。在此，我们报告了通过使用三质粒系统重建整个生物合成途径，在大肠杆菌中异源生产该化合物的情况。基于该系统，全细胞补料试验与体外酶活性试验相结合，揭示了核苷酸共轭的一种不寻常的功能作用，并导致了对先前未确定的后期生物合成步骤的完整阐明。这些研究还提出了第二种膦酸酯抗生素FR-33289的生物合成途径。对FR-900098生物合成途径的透彻理解，为在大肠杆菌中进行代谢工程以提高抗疟抗生素的产量以及进行组合生物合成以生成FR-900098的新型衍生物开辟了可能性。
相似文献
1
Deciphering the late biosynthetic steps of antimalarial compound FR-900098.解析抗疟化合物FR-900098的后期生物合成步骤。
Chem Biol. 2010 Jan 29;17(1):57-64. doi: 10.1016/j.chembiol.2009.12.009.
2
Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product.大肠杆菌能够高效地将新分离的醌霉素生物合成酶模块化整合到棘霉素生物合成途径中，用于合理设计和合成强效抗生素非天然天然产物。
J Am Chem Soc. 2009 Jul 8;131(26):9347-53. doi: 10.1021/ja902261a.
3
The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.大肠杆菌1-脱氧-D-木酮糖-5-磷酸还原异构酶与抗疟化合物磷霉素和NADPH形成的三元复合物的晶体结构揭示了一种紧密结合的封闭酶构象。
J Mol Biol. 2005 Jan 7;345(1):115-27. doi: 10.1016/j.jmb.2004.10.030.
4
Heterologous production of ribostamycin derivatives in engineered Escherichia coli.工程大肠杆菌中瑞鲍迪霉素衍生物的异源生产。
Res Microbiol. 2010 Sep;161(7):526-33. doi: 10.1016/j.resmic.2010.04.013. Epub 2010 Jun 16.
5
[Biosynthesis of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli through introducing mevalonate pathway].通过引入甲羟戊酸途径在大肠杆菌中生物合成抗疟药物青蒿素的前体 amorpha-4,11-二烯
Sheng Wu Gong Cheng Xue Bao. 2011 Jul;27(7):1040-8.
6
Engineering Escherichia coli FAB system using synthetic plant genes for the production of long chain fatty acids.利用合成植物基因工程大肠杆菌 FAB 系统生产长链脂肪酸。
Microb Cell Fact. 2019 Oct 3;18(1):163. doi: 10.1186/s12934-019-1217-7.
7
A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.细胞代谢轮廓分析揭示抗疟和抗菌剂福米霉素的第二个作用靶点。
Biochemistry. 2011 May 3;50(17):3570-7. doi: 10.1021/bi200113y. Epub 2011 Apr 11.
8
Structure-guided design and biosynthesis of a novel FR-900098 analogue as a potent Plasmodium falciparum 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr) inhibitor.新型FR-900098类似物作为强效恶性疟原虫1-脱氧-D-木酮糖-5-磷酸还原异构酶（Dxr）抑制剂的结构导向设计与生物合成
Chem Commun (Camb). 2015 Feb 14;51(13):2526-8. doi: 10.1039/c4cc09181g.
9
Molecular variation of the nonribosomal peptide-polyketide siderophore yersiniabactin through biosynthetic and metabolic engineering.通过生物合成和代谢工程实现非核糖体肽-聚酮类铁载体耶尔森菌素的分子变异
Biotechnol Bioeng. 2016 May;113(5):1067-74. doi: 10.1002/bit.25872. Epub 2015 Nov 20.
10
Genomic Deoxyxylulose Phosphate Reductoisomerase (DXR) Mutations Conferring Resistance to the Antimalarial Drug Fosmidomycin in E. coli.基因组脱氧木酮糖磷酸还原异构酶（DXR）突变赋予大肠杆菌对抗疟药物磷霉素的抗性。
ACS Synth Biol. 2018 Dec 21;7(12):2824-2832. doi: 10.1021/acssynbio.8b00219. Epub 2018 Dec 7.
引用本文的文献
1
Genetic Encoding of Phosphorylated Amino Acids into Proteins.磷酸化氨基酸在蛋白质中的遗传编码。
Chem Rev. 2024 May 22;124(10):6592-6642. doi: 10.1021/acs.chemrev.4c00110. Epub 2024 May 1.
2
Autonomous Synthesis of Functional, Permanently Phosphorylated Proteins for Defining the Interactome of Monomeric 14-3-3ζ.用于定义单体14-3-3ζ相互作用组的功能性、永久磷酸化蛋白质的自主合成
ACS Cent Sci. 2023 Apr 10;9(4):816-835. doi: 10.1021/acscentsci.3c00191. eCollection 2023 Apr 26.
3
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities.超过40年的磷霉素药物研究：全面综述与未来机遇
Pharmaceuticals (Basel). 2022 Dec 14;15(12):1553. doi: 10.3390/ph15121553.
4
Convergent and divergent biosynthetic strategies towards phosphonic acid natural products.磷酸天然产物的汇聚和发散生物合成策略。
Curr Opin Chem Biol. 2022 Dec;71:102214. doi: 10.1016/j.cbpa.2022.102214. Epub 2022 Oct 3.
5
An Unusual Oxidative Rearrangement Catalyzed by a Divergent Member of the 2-Oxoglutarate-Dependent Dioxygenase Superfamily during Biosynthesis of Dehydrofosmidomycin.在去氢呋喃霉素生物合成过程中，2-氧代戊二酸依赖的双加氧酶超家族的一个分支成员催化了一种不寻常的氧化重排反应。
Angew Chem Int Ed Engl. 2022 Jul 25;61(30):e202206173. doi: 10.1002/anie.202206173. Epub 2022 Jun 7.
6
The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic.磷霉素引人入胜的生物学与化学特性：唯一上市的膦酸酯类抗生素。
RSC Adv. 2019 Dec 19;9(72):42204-42218. doi: 10.1039/c9ra08299a. eCollection 2019 Dec 18.
7
PermaPhos : autonomous synthesis of functional, permanently phosphorylated proteins.PermaPhos：功能性永久磷酸化蛋白的自主合成
bioRxiv. 2021 Dec 14:2021.10.22.465468. doi: 10.1101/2021.10.22.465468.
8
Fosmidomycin biosynthesis diverges from related phosphonate natural products.福米霉素生物合成与相关膦酸酯天然产物不同。
Nat Chem Biol. 2019 Nov;15(11):1049-1056. doi: 10.1038/s41589-019-0343-1. Epub 2019 Aug 26.
9
The predominance of nucleotidyl activation in bacterial phosphonate biosynthesis.核苷酸在细菌膦酸生物合成中的优势。
Nat Commun. 2019 Aug 16;10(1):3698. doi: 10.1038/s41467-019-11627-6.
10
Characterization of the flavin monooxygenase involved in biosynthesis of the antimalarial FR-900098.鉴定参与抗疟化合物 FR-900098 生物合成的黄素单加氧酶。
Org Biomol Chem. 2019 Feb 6;17(6):1506-1518. doi: 10.1039/c8ob02840k.
本文引用的文献
1
Cloning, expression, and biochemical characterization of Streptomyces rubellomurinus genes required for biosynthesis of antimalarial compound FR900098.抗疟化合物FR900098生物合成所需的红褐链霉菌基因的克隆、表达及生化特性分析
Chem Biol. 2008 Aug 25;15(8):765-70. doi: 10.1016/j.chembiol.2008.07.010.
2
Synthesis of the antimalarial drug FR900098 utilizing the nitroso-ene reaction.
Org Lett. 2007 Oct 11;9(21):4379-82. doi: 10.1021/ol702082k. Epub 2007 Sep 22.
3
Unusual transformations in the biosynthesis of the antibiotic phosphinothricin tripeptide.抗生素草丁膦三肽生物合成中的异常转变。
Nat Chem Biol. 2007 Aug;3(8):480-5. doi: 10.1038/nchembio.2007.9. Epub 2007 Jul 15.
4
Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster.磷霉素的异源生产及最小生物合成基因簇的鉴定。
Chem Biol. 2006 Nov;13(11):1171-82. doi: 10.1016/j.chembiol.2006.09.007.
5
Fosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malaria.磷霉素氨丁三醇联合克林霉素治疗1至14岁儿童恶性疟原虫疟疾。
Antimicrob Agents Chemother. 2006 Aug;50(8):2713-8. doi: 10.1128/AAC.00392-06.
6
The Nudix hydrolase superfamily.Nudix水解酶超家族。
Cell Mol Life Sci. 2006 Jan;63(2):123-43. doi: 10.1007/s00018-005-5386-7.
7
The global distribution of clinical episodes of Plasmodium falciparum malaria.恶性疟原虫疟疾临床发作的全球分布情况。
Nature. 2005 Mar 10;434(7030):214-7. doi: 10.1038/nature03342.
8
Molecular cloning, sequence analysis, and heterologous expression of the phosphinothricin tripeptide biosynthetic gene cluster from Streptomyces viridochromogenes DSM 40736.来自绿色产色链霉菌DSM 40736的草丁膦三肽生物合成基因簇的分子克隆、序列分析及异源表达
Antimicrob Agents Chemother. 2005 Jan;49(1):230-40. doi: 10.1128/AAC.49.1.230-240.2005.
9
Biosynthetic gene cluster of the herbicide phosphinothricin tripeptide from Streptomyces viridochromogenes Tü494.来自绿色产色链霉菌Tü494的除草剂草丁膦三肽的生物合成基因簇。
Appl Environ Microbiol. 2004 Dec;70(12):7093-102. doi: 10.1128/AEM.70.12.7093-7102.2004.
10
The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation.大肠杆菌1-脱氧-D-木酮糖-5-磷酸还原异构酶与抗疟化合物磷霉素和NADPH形成的三元复合物的晶体结构揭示了一种紧密结合的封闭酶构象。
J Mol Biol. 2005 Jan 7;345(1):115-27. doi: 10.1016/j.jmb.2004.10.030.
Zotero 插件